BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6421498)

  • 1. Toxic effects of 2-methyl-4-dimethylaminoazobenzene in normal and partially hepatectomized rats.
    Daoust R
    Chem Biol Interact; 1984 Feb; 48(2):221-35. PubMed ID: 6421498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of fumaric acid on 3-methyl-4'-(dimethylamino)-azobenzene-induced hepatocarcinogenesis in rats.
    Kuroda K; Terao K; Akao M
    J Natl Cancer Inst; 1983 Oct; 71(4):855-7. PubMed ID: 6413745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promotion of hepatocarcinogenesis by suxibuzone in rats initiated with 3'-methyl-4-dimethylaminoazobenzene.
    Yanagi S; Sakamoto M; Takahashi S; Tsutsumi M; Konishi Y; Shibata K; Kamiya T
    Cancer Lett; 1987 Jul; 36(1):11-8. PubMed ID: 3107799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of inhibition by simultaneously administered phenobarbital of 3'-methyl-4-(dimethylamino)azobenzene-induced hepatocarcinogenesis in the rat.
    Natria T; Watanabe R; Kitagawa T
    Gan; 1980 Dec; 71(6):755-8. PubMed ID: 6791981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of hyperplastic liver nodules in hepatectomized rats treated with 3'-methyl-4-dimethylaminoazobenzene, benzo[a]pyrene or phenobarbital before or after exposure to N-2-fluorenylacetamide.
    Hasegawa R; Tatematsu M; Tsuda H; Shirai T; Hagiwara A; Ito N
    Gan; 1982 Apr; 73(2):264-9. PubMed ID: 6288500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumorigenicity of 3'-hydroxymethyl, 3'-formyl, and 3'-carboxy derivatives of 4-(dimethylamino)azobenzene in rat liver.
    Mori Y; Nagai H; Hori T; Niwa T; Toyoshi K; Koda A; Kawada K; Ojima A
    Gan; 1981 Feb; 72(1):160-5. PubMed ID: 6791985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of monoamine oxidase by 3'-methyl-4-dimethylamino azobenzene (3'-me-DAB) in rat liver mitochondria.
    Egashira T; Yamamoto T; Kuroiwa Y
    Jpn J Pharmacol; 1982 Apr; 32(2):335-42. PubMed ID: 6808207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different responses other than the formation of DNA-adducts between the livers of carcinogen-resistant rats (DRH) and carcinogen-sensitive rats (Donryu) to 3'-methyl-4-dimethylaminoazobenzene administration.
    Yan Y; Higashi K; Yamamura K; Fukamachi Y; Abe T; Gotoh S; Sugiura T; Hirano T; Higashi T; Ichiba M
    Jpn J Cancer Res; 1998 Aug; 89(8):806-13. PubMed ID: 9765615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. gamma-Glutamyltransferase and the inhibition of azo dye-produced neoplasia by concomitant administration of disulfiram.
    Fiala S; Trout EC; Ostrander H; Fiala AE
    J Natl Cancer Inst; 1980 Feb; 64(2):267-71. PubMed ID: 6101622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of 3'-methyl-4-dimethylaminoazobenezene-induced hepatocarcinogenesis by portacaval shunt.
    Fiala S; Pragani B; Reuber MD
    Tumori; 1978 Apr; 64(2):131-42. PubMed ID: 27891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferential inhibition of the B-form of monoamine oxidase in the liver of rats given 3'-methyl-4-dimethylaminoazobenzene in the diet.
    Egashira T; Yamamoto T; Yamanaka Y; Kuroiwa Y
    Biochem Pharmacol; 1982 Apr; 31(7):1301-7. PubMed ID: 6807318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of hepatocellular carcinoma development and erythrocyte polyamine levels in ODS rats fed on 3'-methyl-4-dimethylaminoazobenzene by hemicalcium ascorbate, 2-O-octadecylascorbic acid, and ascorbyl palmitate.
    Shimpo K; Takahashi H; Tsuda H; Hibino T; Kawai K; Kimura C; Nagatsu T; Fujita K
    Cancer Detect Prev; 1996; 20(2):137-45. PubMed ID: 8706039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo and in vitro test for growth potential of liver cells from rats during early stage of hepatocarcinogenesis by 3'-methyl-4-dimethylaminoazobenzene.
    Miyazaki M; Wahid S; Sato J
    J Cancer Res Clin Oncol; 1989; 115(1):1-8. PubMed ID: 2921269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NADPH-dependent lipid peroxidation in the liver microsome of rats fed a 3'-methyl-4-dimethyl-aminoazobenzene (3'-Me-DAB)-containing diet.
    Yamamoto T; Egashira T; Yamanaka Y
    Jpn J Pharmacol; 1983 Oct; 33(5):1100-3. PubMed ID: 6417386
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibitory effect of fumaric acid on 3'-methyl-4-(dimethylamino)azobenzene-induced hepatocarcinogenesis in rats.
    Kuroda K; Akao M
    Chem Pharm Bull (Tokyo); 1989 May; 37(5):1345-6. PubMed ID: 2517046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiorespirometric analysis of glucose metabolism in the rat during feeding with 3'-methyl-4-(dimethylamino)azobenzene--radiorespirometry after partial hepatectomy.
    Kojima S; Yamamoto M; Odate M; Kubodera A
    Radioisotopes; 1979 Sep; 28(9):546-50. PubMed ID: 120561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of 3'-methyl-4-dimethylaminoazobenzene in the induction of malignant transformation and of 8-azaguanine-resistant mutations and chromosomal aberrations in a diploid clone derived from normal rat liver cells in culture.
    Tokiwa T; Sato J
    In Vitro; 1982 Jun; 18(6):501-9. PubMed ID: 6811416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic properties for the suppression of development of putative preneoplastic glutathione S-transferase placental form-positive foci in the liver of carcinogen-resistant DRH strain rats.
    Denda A; Kitayama W; Konishi Y; Yan Y; Fukamachi Y; Miura M; Gotoh S; Ikemura K; Abe T; Higashi T; Higashi K
    Cancer Lett; 1999 Jun; 140(1-2):59-67. PubMed ID: 10403542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoting effects of phenobarbital and 3'-methyl-4-dimethylaminoazobenzene on the appearance of gamma-glutamyltranspeptidase positive foci in rat liver pretreated with varying doses of diethylnitrosamine.
    Shirai T; Hosoda K; Hirose K; Hirose M; Ito N
    Cancer Lett; 1985 Sep; 28(2):127-33. PubMed ID: 2865001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of hepatocarcinogenesis by sorbitan fatty acid ester, a liver pyruvate kinase activity-reducing substance.
    Yanagi S; Sakamoto M; Takahashi S; Hasuike A; Konishi Y; Kumazawa K; Nakano T
    J Natl Cancer Inst; 1985 Aug; 75(2):381-4. PubMed ID: 3860690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.